Transparency and reporting characteristics of COVID-19 randomized controlled trials.

Philipp KappLaura EsmailLina GhosnPhilippe RavaudIsabelle Boutron

Published in: BMC medicine (2022)

Transparency, completeness, and consistency of reporting of COVID-19 clinical trials were insufficient both in preprints and peer-reviewed publications. A comparison of paired reports published in preprint and peer-reviewed publication did not indicate major improvement.

Keyphrases

coronavirus disease
sars cov
adverse drug
clinical trial
randomized controlled trial
respiratory syndrome coronavirus
meta analyses
emergency department
systematic review
phase ii
phase iii
drug induced